Effective Date Contract Clauses (7,237)

Grouped Into 65 Collections of Similar Clauses From Business Contracts

This page contains Effective Date clauses in business contracts and legal agreements. We have organized these clauses into groups of similarly worded clauses.
Effective Date. Employee understands that this Agreement shall be null and void if not executed by him within twenty one (21) days. Employee has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Employee signed this Agreement, so long as it has been signed by the Parties and has not been revoked by Employee before that date (the "Effective Date").
Effective Date. Employee Executive understands that this Agreement shall be null and void if not executed by him Executive within twenty one twenty-one (21) days. Employee Each Party has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Employee Executive signed this Agreement, so long as it has been signed by the Parties and has not been revoked by Employee either Party before that date (the "Effective Date").
Effective Date. Employee understands that this Agreement shall be null and void if not executed by him her within twenty one twenty-one (21) days. days from the date this Agreement is presented. Employee has seven (7) days after that Party she signs this Agreement to revoke it. To be effective, any such revocation must be made in writing and delivered to John Foster on or before 5:00 p.m. PT on the seventh (7th) day. This Agreement will become effective on the eighth (8th) day after Employee signed this... Agreement, so long as it has been signed by the Parties and has not been revoked by Employee before that date (the "Effective ("Effective Date"). View More Arrow
Effective Date. Employee Executive understands that this Agreement shall be null and void if not executed by him within twenty one (21) days. Employee days of the date this Agreement is presented to him by the Company. Executive has seven (7) days after that Party Executive signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Employee Executive signed this Agreement, so long as it has been signed by the Parties and has not been revoked by Employee Executive... before that date (the "Effective Date"). View More Arrow
View Variations (11) Arrow
Effective Date. This Plan shall take effect on the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 12 APPENDIX A Designated Subsidiaries 13 EX-10.4 14... d120909dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 CANDEL THERAPEUTICS, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN The purpose of the Candel Therapeutics, Inc. 2021 Employee Stock Purchase Plan (the "Plan") is to provide eligible employees of Candel Therapeutics, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.01 per share (the "Common Stock"). An aggregate of 293,000 shares of Common Stock have been approved and reserved for this purpose, plus on January 1, 2022, and each January 1 thereafter through January 1, 2031 the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) 293,000 shares of Common Stock, (ii) one percent (1%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, or (iii) such number of shares of Common Stock as determined by the Administrator (as defined in Section 1). The Plan includes two components: a Code Section 423 Component (the "423 Component") and a non-Code Section 423 Component (the "Non-423 Component"). It is intended for the 423 Component to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423 Component, which does not qualify as an "employee stock purchase plan" within the meaning of Section 423(b) of the Code, options will be granted pursuant to rules, procedures or sub-plans adopted by the Administrator designed to achieve tax, securities laws or other objectives for eligible employees. Except as otherwise provided herein, the Non-423 Component will operate and be administered in the same manner as the 423 Component. Unless otherwise defined herein, capitalized terms in this Plan shall have the meaning ascribed to them in Section 11. View More Arrow
Effective Date. This Plan shall take effect on become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission Registration Date following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 12 APPENDIX A... Designated Subsidiaries 13 EX-10.4 14 d120909dex104.htm 6 d692551dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 CANDEL THERAPEUTICS, PHREESIA, INC. 2021 2019 EMPLOYEE STOCK PURCHASE PLAN The purpose of the Candel Therapeutics, Phreesia, Inc. 2021 2019 Employee Stock Purchase Plan (the "Plan") ("the Plan") is to provide eligible employees of Candel Therapeutics, Phreesia, Inc. (the "Company") and each Designated Subsidiary Company (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.01 $0.001 per share (the "Common Stock"). An aggregate of 293,000 855,873 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2022, and each January 1 thereafter through January 1, 2031 the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) 293,000 shares of Common Stock, (ii) one percent (1%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, or (iii) such number of shares of Common Stock as determined by the Administrator (as defined in Section 1). purpose. The Plan includes two components: a Code Section 423 Component (the "423 Component") and a non-Code Section 423 Component (the "Non-423 Component"). It is intended for the 423 Component to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), "Code") and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423 Component, which does not qualify as an "employee stock purchase plan" within the meaning of Section 423(b) of the Code, options will be granted pursuant to rules, procedures or sub-plans adopted by the Administrator designed to achieve tax, securities laws or other objectives for eligible employees. Except as otherwise provided herein, herein or by the Administrator, the Non-423 Component will operate and be administered in the same manner as the 423 Component. Unless otherwise defined herein, capitalized terms in this the Plan shall have the meaning ascribed to them in Section 11. View More Arrow
Effective Date. This Plan shall take effect on become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission Registration Date following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 12 APPENDIX A... Designated Subsidiaries 13 EX-10.4 14 d120909dex104.htm EX-10.4 EX-10.4 7 EX-10.2 10 d668054dex102.htm EX-10.2 EX-10.2 Exhibit 10.4 CANDEL THERAPEUTICS, 10.2 DYNATRACE, INC. 2021 2019 EMPLOYEE STOCK PURCHASE PLAN The purpose of the Candel Therapeutics, Dynatrace, Inc. 2021 2019 Employee Stock Purchase Plan (the "Plan") ("the Plan") is to provide eligible employees of Candel Therapeutics, Dynatrace, Inc. (the "Company") and each Designated Subsidiary Company (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.01 $0.001 per share (the "Common Stock"). An aggregate of 293,000 6,250,000 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January April 1, 2022, 2020, and each January April 1 thereafter through January April 1, 2031 2029, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) 293,000 shares of Common Stock, (ii) one 1% percent (1%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December March 31st, (ii) 3,500,000 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator (as defined in Section 1). The Plan includes two components: a Code Section 423 Component (the "423 Component") and a non-Code Section 423 Component (the "Non-423 Component"). It is intended for the 423 Component to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423 Component, which does not qualify as an "employee stock purchase plan" within the meaning of Section 423(b) of the Code, options will be granted pursuant to rules, procedures or sub-plans adopted by the Administrator designed to achieve tax, securities comply with applicable laws or achieve tax and other objectives for eligible employees. objectives. Except as otherwise provided herein, herein or by the Administrator, the Non-423 Component will operate and be administered in the same manner as the 423 Component. Unless otherwise defined herein, capitalized terms in this Plan shall have the meaning ascribed to them in Section 11. View More Arrow
Effective Date. This Plan shall take effect on become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 12 11 APPENDIX A Designated Subsidiaries ... class="diff-color-red">13 EX-10.4 14 d120909dex104.htm EX-10.4 EX-10.4 12 EX-10.13 16 tm2032047d11_ex10-13.htm EXHIBIT 10.13 Exhibit 10.4 CANDEL THERAPEUTICS, 10.13 908 DEVICES INC. 2021 2020 EMPLOYEE STOCK PURCHASE PLAN The purpose of the Candel Therapeutics, 908 Devices Inc. 2021 2020 Employee Stock Purchase Plan (the "Plan") is to provide eligible employees of Candel Therapeutics, 908 Devices Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.01 $0.001 per share (the "Common Stock"). An aggregate of 293,000 288,857 shares of Common Stock have been approved and reserved for this purpose, plus on January 1, 2022, and each January 1 thereafter through January 1, 2031 2030, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) 293,000 307,295 shares of Common Stock, (ii) one percent (1%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, or (iii) such number of shares of Common Stock as determined by the Administrator (as defined in Section 1). The Plan includes two components: a Code Section 423 Component (the "423 Component") and a non-Code Section 423 Component (the "Non-423 Component"). It is intended for the 423 Component to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423 Component, which does not qualify as an "employee stock purchase plan" within the meaning of Section 423(b) of the Code, options will be granted pursuant to rules, procedures or sub-plans adopted by the Administrator designed to achieve tax, securities laws or other objectives for eligible employees. Except as otherwise provided herein, the Non-423 Component will operate and be administered in the same manner as the 423 Component. Unless otherwise defined herein, capitalized terms in this Plan shall have the meaning ascribed to them in Section 11. View More Arrow
View Variations (10) Arrow
Effective Date. The MHC Merger shall not be effective until and unless the Plan is approved by the Board of Governors of the Federal Reserve System (the "Federal Reserve") after approval of this MHC Merger Agreement by at least (i) two-thirds of the votes eligible to be cast by the Stockholders of the Mid-Tier Holding Company, (ii) a majority of the votes eligible to be cast by Minority Stockholders, and (iii) a majority of the votes eligible to be cast by Voting Members, and the Articles of Combination shall... have been filed with the Federal Reserve with respect to the MHC Merger. Approval of the Plan by the Voting Members shall constitute approval of the MHC Merger Agreement by the Voting Members. Approval of the Plan by Minority Stockholders of the Mid-Tier Holding Company, including the Minority Stockholders, shall constitute approval of the MHC Merger Agreement by such stockholders. View More Arrow
Effective Date. The MHC Merger shall not be effective until and unless the Plan is approved by the Board of Governors of the Federal Reserve System (the "Federal Reserve") after approval of this MHC Merger Agreement by at least least: (i) two-thirds of the total votes eligible to be cast by the Stockholders of the Mid-Tier Holding Company, Stockholders; (ii) a majority of the total votes eligible to be cast by Minority Stockholders, Stockholders; and (iii) a majority of the votes eligible to be cast by Voting... Members, and the Articles of Combination shall have been filed with the Federal Reserve with respect to the MHC Merger. Approval of the Plan by the Voting Members shall constitute approval of the this MHC Merger Agreement by the Voting Members. Approval of the Plan by Minority Stockholders of the Mid-Tier Holding Company, Stockholders, including the Minority Stockholders, shall constitute approval of the this MHC Merger Agreement by such stockholders. the Stockholders. View More Arrow
Effective Date. The MHC Merger shall not be effective until and unless the Plan is approved by the Board of Governors of the Federal Reserve System (the "Federal Reserve") after approval of this MHC Merger Agreement by by: (i) at least (i) two-thirds of the total votes eligible to be cast by the Stockholders of the Mid-Tier Holding Company, Stockholders; (ii) a majority of the total votes eligible to be cast by Minority Stockholders, Stockholders; and (iii) a majority of the votes eligible to be cast by Voting... Members, and the Articles of Combination shall have been filed with the Federal Reserve with respect to the MHC Merger. Approval of the Plan by the Voting Members shall constitute approval of the this MHC Merger Agreement by the Voting Members. Approval of the Plan by Minority Stockholders of the Mid-Tier Holding Company, Stockholders, including the Minority Stockholders, shall constitute approval of the this MHC Merger Agreement by such stockholders. the Stockholders. View More Arrow
Effective Date. The MHC Merger shall not be effective until and unless the Plan is approved by the Board of Governors of the Federal Reserve System (the "Federal Reserve") and the Department after approval of this MHC Merger Agreement by (i) at least (i) two-thirds of the votes eligible to be cast by the Stockholders of the Mid-Tier Holding Company, (ii) a majority of the votes eligible to be cast by Minority Stockholders, and (iii) a majority of the votes eligible to be cast by Voting Members, Depositors, and... the Articles Certificate of Combination Merger shall have been filed with the Federal Reserve applicable state authorities with respect to the MHC Merger. Approval of the Plan by the Voting Members Depositors shall constitute approval of the MHC Merger Agreement by the Voting Members. Depositors. Approval of the Plan by Minority Stockholders of the Mid-Tier Holding Company, including the Minority Stockholders, shall constitute approval of the MHC Merger Agreement by such stockholders. Stockholders. View More Arrow
View Variations (6) Arrow
Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None 11 EX-10.3 8... tv527886_ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 SPRINGWORKS THERAPEUTICS, INC. 2019 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("the Plan") is to provide eligible employees of SpringWorks Therapeutics, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). An aggregate of 442,153 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, and each January 1 thereafter through January 1, 2029, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More Arrow
Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None None. 11... EX-10.3 8 tv527886_ex10-3.htm 13 a2238646zex-10_3.htm EX-10.3 EXHIBIT 10.3 Exhibit 10.3 SPRINGWORKS THERAPEUTICS, AXCELLA HEALTH INC. 2019 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Therapeutics, Axcella Health Inc. 2019 Employee Stock Purchase Plan ("the Plan") is to provide eligible employees of SpringWorks Therapeutics, Axcella Health Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 $0.001 per share (the "Common Stock"). An aggregate of 442,153 237,181 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, and each January 1 thereafter through January 1, 2029, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 237,181 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More Arrow
Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. DATE APPROVED BY BOARD OF DIRECTORS: AUGUST 11, 2020... DATE APPROVED BY STOCKHOLDERS: AUGUST 14, 2020 10 APPENDIX A Designated Subsidiaries None None. 11 EX-10.3 8 tv527886_ex10-3.htm EXHIBIT 10.3 EX-10.5 9 d940105dex105.htm EX-10.5 EX-10.5 Exhibit 10.3 SPRINGWORKS 10.5 KYMERA THERAPEUTICS, INC. 2019 2020 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Kymera Therapeutics, Inc. 2019 2020 Employee Stock Purchase Plan ("the Plan") (the "Plan") is to provide eligible employees of SpringWorks Kymera Therapeutics, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). An aggregate of 442,153 445,653 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, 2021, and each January 1 thereafter through January 1, 2029, 2030, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 438,898 shares of Common Stock Stock, or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More Arrow
Effective Date. This Plan shall become effective upon the date immediately preceding the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission following stockholder approval in accordance with applicable state law, the Company's bylaws and articles of incorporation, each as amended, and applicable stock exchange rules. 10 APPENDIX A Designated Subsidiaries None 11 EX-10.3 8... tv527886_ex10-3.htm EXHIBIT 10.3 EX-10.11 13 d945651dex1011.htm EX-10.11 EX-10.11 Exhibit 10.3 SPRINGWORKS THERAPEUTICS, 10.11 PRAXIS PRECISION MEDICINES, INC. 2019 2020 EMPLOYEE STOCK PURCHASE PLAN The purpose of the SpringWorks Therapeutics, Praxis Precision Medicines, Inc. 2019 2020 Employee Stock Purchase Plan ("the Plan") (the "Plan") is to provide eligible employees of SpringWorks Therapeutics, Praxis Precision Medicines, Inc. (the "Company") and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). An aggregate of 442,153 327,102 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2020, 2021, and each January 1 thereafter through January 1, 2029, 2030, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) one percent (1%) percent of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, (ii) 663,229 327,102 shares of Common Stock or (iii) such number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an "employee stock purchase plan" within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the "Code"), and shall be interpreted in accordance with that intent. View More Arrow
View Variations (5) Arrow
Effective Date. Employee understands that this Agreement shall be null and void if not executed by Employee and received by the Company on or before October 1, 2021. This Agreement will become effective on the date it has been signed by both Parties (the "Effective Date").
Effective Date. Employee understands that this Agreement shall be null and void if not executed by Employee and received by the Company on or before October 1, 2021. within seven (7) days. This Agreement will become effective on the date it has been signed by both Parties (the "Effective Date").
Effective Date. Employee understands that this Agreement shall be null and void if not executed by Employee and received by the Company on or before October 1, November 12, 2021. This Agreement will become effective on the date it has been signed by both Parties (the "Effective Date").
View Variations (4) Arrow
Effective Date. This Amendment shall become effective as of the Amendment Effective Date.
Effective Date. This Amendment shall become be effective as of the Amendment Effective Date.
Effective Date. This Amendment shall become effective as of the Second Amendment Effective Date.
View Variations (3) Arrow
Effective Date. This Amendment shall become effective (the "Third Amendment Effective Date") as of September 30, 2014 once the conditions set forth in Section 4 of this Amendment are satisfied or waived.
Effective Date. This Amendment shall become effective (the "Third "Fourth Amendment Effective Date") as of September 30, December 31, 2014 once the conditions set forth in Section 4 of this Amendment are satisfied or waived.
View Variations (2) Arrow
Effective Date. The provisions of this Agreement shall cover claims, actions, suits or proceedings whether now pending or hereafter commenced and shall be retroactive to cover acts or omissions or alleged acts or omissions which heretofore have taken place. The Company shall be liable under this Agreement, pursuant to Sections 3 and 4 of this Agreement, for all acts of the Indemnitee while serving as a director and/or officer, notwithstanding the termination of the Indemnitee's service, if such act was... performed or omitted to be performed during the term of the Indemnitee's service to the Company. View More Arrow
Effective Date. The provisions of this Agreement shall cover claims, actions, suits claims or proceedings Proceedings whether now pending or hereafter commenced and shall be retroactive to cover acts or omissions or alleged acts or omissions which heretofore have taken place. The Company shall be liable under this Agreement, pursuant to Sections 3 4 and 4 of this Agreement, for all acts of the Indemnitee while serving as a director and/or officer, 5, notwithstanding the termination of the Indemnitee's service,... if the rights of indemnification under such act was performed or omitted Sections relate to be performed during the term of the Indemnitee's service to the Company. View More Arrow
Effective Date. The provisions of this Agreement shall cover claims, actions, suits or proceedings whether now pending or hereafter commenced and shall be retroactive to cover acts or omissions or alleged acts or omissions which heretofore have taken place. The Company shall be liable under this Agreement, pursuant to Sections 3 and the extent specified in Section 1, 2, 3, 4 of this Agreement, or 8 hereof, for all acts and omissions of the Indemnitee while serving as a director and/or or officer,... notwithstanding the termination of the Indemnitee's service, if such act was performed or omitted to be performed during the term of the Indemnitee's service to the Company. View More Arrow
View Variations (2) Arrow
Effective Date. This Agreement shall take effect as of , which is the date of grant of the Award (the "Grant Date").
Effective Date. This Agreement shall take effect as of , May 2, 2018, which is the date of grant of the Award (the "Grant Date").
Effective Date. This Agreement shall take effect as of , 2014, which is the date of grant of the Award (the "Grant Date").
View Variations (2) Arrow
Effective Date. This General Release shall become effective only upon (a) execution of this General Release by Employee after the expiration of the twenty-one (21) day consideration period described in § 3 of this General Release, unless such consideration period is voluntarily shortened as provided by law; and (b) the expiration of the seven (7) day period for revocation of this General Release by Employee described in § 4 of this General Release. CAUTION TO EMPLOYEE: READ BEFORE SIGNING. THIS DOCUMENT... CONTAINS A RELEASE OF ALL CLAIMS AGAINST THE COMPANY ENTITIES PRIOR TO THE EFFECTIVE DATE OF THIS GENERAL RELEASE OF CLAIMS. DATE OF EXECUTION BY EMPLOYEE: AGREED TO AND ACCEPTED BY: ___________________________________ John P. Daly EXECUTION WITNESSED BY: DATE OF EXECUTION BY COMPANY: AGREED TO AND ACCEPTED BY CRAWFORD UNITED CORPORATION ___________________________________ BY:_______________________________ TITLE:____________________________ EXECUTION WITNESSED BY: ___________________________________ -3- EX-10.1 2 ex_496083.htm EXHIBIT 10.1 ex_496083.htm Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS ("Agreement"), is made and entered into by and between Crawford United Corporation, an Ohio corporation (the "Company"), and John P. Daly ("Employee"), with an Effective Date as described below. W I T N E S S E T H: WHEREAS, Employee has been employed by the Company as its Vice President and Chief Financial Officer; WHEREAS, on or about March 29, 2023, Employee provided notice of his voluntary resignation from employment with the Company, with such voluntary resignation to be effective April 30, 2023; and WHEREAS, the Company and Employee wish to resolve all matters and issues between them arising from or relating to Employee's employment by the Company and Employee's resignation from employment. NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, Employee and the Company hereby agree as follows: 1. Resignation. Employee, through his signature below, voluntarily resigns from his employment with the Company effective April 30, 2023 ("Date of Resignation"). Employee understands that his employment records will reflect the voluntary nature of the cessation of his employment. The Company hereby consents to and accepts Executive's resignation effective as of the Date of Resignation. Employee, through his signature below, also voluntarily resigns as a director, officer, manager, or from other service in any role for each affiliate of the Company, effective as of the Date of Resignation. View More Arrow
Effective Date. This General Release Agreement shall become not be binding on Hub until signed by a representative of Hub. This Agreement shall be effective only upon (a) execution on the later of a) the 8th day after Employee signs this General Release by Employee after Agreement, if not revoked before then, or b) the expiration date Hub signs this Agreement. Name:__/s/Donald Maltby________________ /s/Douglas G. Beck_____________________ On Behalf of the twenty-one (21) day consideration period described in §... 3 of this General Release, unless such consideration period is voluntarily shortened as provided by law; and (b) the expiration of the seven (7) day period for revocation of this General Release by Employee described in § 4 of this General Release. CAUTION TO EMPLOYEE: READ BEFORE SIGNING. THIS DOCUMENT CONTAINS A RELEASE OF ALL CLAIMS AGAINST THE COMPANY ENTITIES PRIOR TO THE EFFECTIVE DATE OF THIS GENERAL RELEASE OF CLAIMS. DATE OF EXECUTION BY EMPLOYEE: AGREED TO AND ACCEPTED BY: ___________________________________ John P. Daly EXECUTION WITNESSED BY: DATE OF EXECUTION BY COMPANY: AGREED TO AND ACCEPTED BY CRAWFORD UNITED CORPORATION ___________________________________ BY:_______________________________ TITLE:____________________________ EXECUTION WITNESSED BY: ___________________________________ -3- Hub Group, Inc. Dated:_7/11/2019_____________________Dated:_7/15/2019_____________________ EX-10.1 2 ex_496083.htm EXHIBIT 10.1 ex_496083.htm hubg-ex101_27.htm EX-10.1 hubg-ex101_27.htm Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS ("Agreement"), This Separation Agreement (the "Agreement") is made between Donald Maltby, on behalf of himself, his spouse, beneficiaries, heirs, agents, successors, assigns, dependents, and entered into by anyone acting on his behalf (collectively referred to throughout this Agreement as "Employee"), and between Crawford United Corporation, an Ohio corporation (the "Company"), Hub Group, Inc., on behalf of itself, its subsidiaries, affiliate companies, directors, officers, predecessors, successors, employees, general partners, agents and John P. Daly ("Employee"), with an Effective Date anyone acting for it (collectively referred to throughout this Agreement as described below. W I T N E S S E T H: WHEREAS, Employee has been employed by the Company as its Vice President and Chief Financial Officer; WHEREAS, on or about March 29, 2023, Employee provided notice of his voluntary resignation from employment with the Company, with such voluntary resignation to be effective April 30, 2023; and WHEREAS, the Company and Employee wish to resolve all matters and issues between them arising from or relating to Employee's employment by the Company and Employee's resignation from employment. NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, Employee and the Company hereby agree as follows: 1. Resignation. Employee, through his signature below, voluntarily resigns from his employment with the Company effective April 30, 2023 ("Date of Resignation"). Employee understands that his employment records will reflect the voluntary nature of the cessation of his employment. The Company hereby consents to and accepts Executive's resignation effective as of the Date of Resignation. Employee, through his signature below, also voluntarily resigns as a director, officer, manager, or from other service in any role for each affiliate of the Company, effective as of the Date of Resignation. "Hub"). View More Arrow
Effective Date. This General Release Effective Date or similar references shall become effective only upon (a) execution be deemed to refer to the last date, in point of time, on which all parties hereto have executed this General Release by Employee after Lease. Designated Address for Landlord: LANDLORD: 1445 Ross Avenue, Suite #5150 Primera Tennyson Partners LLC, a Texas limited Dallas, Texas 75202 liability company Attention: Tennyson Asset Manager By: /s/ Charles Buob Name: Charles Buob and to: Its: CFO... 5600 Tennyson Parkway, Suite #143 Plano, Texas 75024 Attention: Tennyson Property Manager Date: 1/22/14 Designated Address for Tenant: TENANT: 5600 Tennyson Parkway, Suite #240 U.S. Rare Earths, Inc. Plano, Texas 75024 By: /s/ Scott Chrimes_________ Name: Scott Chrimes Its: CFO and to: ______________________________ Date: 01/20/14 ______________________________ ______________________________ EX-10.29 12 uree_ex1029.htm TENNYSON PLACE OFFICE LEASE AGREEMENT uree_ex1029.htm Exhibit 10.29 TENNYSON PLACE OFFICE LEASE AGREEMENT SECTION 1 BASIC TERMS LANDLORD Primera Tennyson Partners LLC, a Texas limited liability company TENANT US Rare Earths, a Mining Company PREMISES RENTABLE AREA (SQ.FT.) 1,588 PROPORTIONATE SHARE (%) 1.597% PREMISES SUITE# 240 LEASE COMMENCEMENT DATE February 1, 2014 LEASE TERM (MONTHS) 32 LEASE EXPIRATION DATE November 30, 2016 BASE RENT(MONTHLY) $3,440.67 TENANT CAR SPACES# 6 SECURITY DEPOSIT $3,440.67 SECTION 2 PREMISES AND TERM 1. Lease of Premises. Landlord leases the expiration Premises to Tenant, and Tenant leases the Premises from Landlord, on the terms and conditions set forth in this Lease. A plan of the twenty-one (21) day consideration period described Premises is attached as Exhibit A (the "Premises"). The Premises are part of that building (the "Building") located at 5600 Tennyson Parkway, Plano, Texas on the 6.67 acre tract of property situated in § 3 the Maria C. Vela Survey, Abstract #935 and being Lot 2, Block A of this General Release, unless such consideration period is voluntarily shortened as provided by law; and (b) the expiration Parkwood Place I in Legacy of the seven (7) day period for revocation map records of this General Release by Employee described in § 4 of this General Release. CAUTION TO EMPLOYEE: READ BEFORE SIGNING. THIS DOCUMENT CONTAINS A RELEASE OF ALL CLAIMS AGAINST THE COMPANY ENTITIES PRIOR TO THE EFFECTIVE DATE OF THIS GENERAL RELEASE OF CLAIMS. DATE OF EXECUTION BY EMPLOYEE: AGREED TO AND ACCEPTED BY: ___________________________________ John P. Daly EXECUTION WITNESSED BY: DATE OF EXECUTION BY COMPANY: AGREED TO AND ACCEPTED BY CRAWFORD UNITED CORPORATION ___________________________________ BY:_______________________________ TITLE:____________________________ EXECUTION WITNESSED BY: ___________________________________ -3- EX-10.1 2 ex_496083.htm EXHIBIT 10.1 ex_496083.htm Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS ("Agreement"), Collin County, Texas which real property is made and entered into by and between Crawford United Corporation, an Ohio corporation known as (the "Company"), and John P. Daly ("Employee"), with an Effective Date as described below. W I T N E S S E T H: WHEREAS, Employee has been employed by the Company as its Vice President and Chief Financial Officer; WHEREAS, on or about March 29, 2023, Employee provided notice of his voluntary resignation from employment with the Company, with such voluntary resignation to be effective April 30, 2023; and WHEREAS, the Company and Employee wish to resolve all matters and issues between them arising from or relating to Employee's employment by the Company and Employee's resignation from employment. NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, Employee "Land"). The Building and the Company hereby agree Land are collectively referred to as follows: 1. Resignation. Employee, through his signature below, voluntarily resigns from his employment with the Company effective April 30, 2023 ("Date of Resignation"). Employee understands that his employment records will reflect the voluntary nature of the cessation of his employment. The Company hereby consents to and accepts Executive's resignation effective as of the Date of Resignation. Employee, through his signature below, also voluntarily resigns as a director, officer, manager, or from other service in any role for each affiliate of the Company, effective as of the Date of Resignation. "Project". View More Arrow
View Variations (2) Arrow